Shankar Balasubramanian is the Herchel Smith Professor of Medicinal Chemistry at the University of Cambridge. He is the co-inventor of the leading next generation sequencing methodology which has made routine, accurate, low-cost sequencing of human genomes a reality. He created Solexa sequencing, co-founded the biotech company Solexa to commercialise the technology and has remained a senior advisor to Solexa then Illumina over the past decade. He has made other seminal contributions to the field of nucleic acids and is a recognised leader of chemical biology and its application to molecular medicine.
Fellow
Back to directory listingProfessor Sir Shankar Balasubramanian FRS FMedSci
Job Title
Herchel Smith Professor of Medicinal Chemistry Senior Group Leader at the Cancer Research UK Cambridge Institute, University of
Institution
University of Cambridge
Year elected
2011
Interests
Specialitieschemical biology, nucleic acids, genome sequencing technology, DNA and RNA targeting drugs, DNA secondary structure, modified DNA bases, epigenetics
Section committee elected byPhysics, chemistry, biochemistry, structural biology, mathematical sciences including statistics, informatics, imaging and engineering applied to biomedicine
Online Information